Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3705)
All Articles published online
|
Feb 28, 2009 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lalazar G, Adar T, Ilan Y. Point-of-care continuous 13C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial. World J Gastroenterol 2009; 15(8): 966-972 [PMID: 19248196 DOI: 10.3748/wjg.15.966] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i8/966.htm |
| Number | Citing Articles |
| 1 |
Yaron Ilan. A fourth dimension in decision making in hepatology. Hepatology Research 2010; 40(12): 1143 doi: 10.1111/j.1872-034X.2010.00737.x
|
| 2 |
Oliver Goetze, Monika Breuer, Andreas Geier, Michael Fried, Achim Weber, Wolfram Jochum, Yaron Ilan, Beat Mullhaupt.
The
13
C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection
. GastroHep 2020; 2(6): 344 doi: 10.1002/ygh2.430
|
| 3 |
Anna Kasicka-Jonderko, Krzysztof Jonderko, Magorzata Budniok, Beata Krusiec-Świdergo, Barbara Bońska-Fajfrowska. Comparison of two dosage regimens of the substrate for the [13C]methacetin breath test. Isotopes in Environmental and Health Studies 2013; 49(1): 109 doi: 10.1080/10256016.2012.707979
|
| 4 |
Giovanni Tarantino. Could quantitative liver function tests gain wide acceptance among hepatologists?. World Journal of Gastroenterology 2009; 15(28): 3457-3461 doi: 10.3748/wjg.15.3457
|
| 5 |
Gadi Lalazar, Yaron Ilan. Assessment of liver function in acute or chronic liver disease by the methacetin breath test: a tool for decision making in clinical hepatology. Journal of Breath Research 2009; 3(4): 047001 doi: 10.1088/1752-7155/3/4/047001
|
| 6 |
Efrat Broide, Haim Shirin. Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetection. Expert Review of Molecular Diagnostics 2015; 15(3): 299 doi: 10.1586/14737159.2015.982537
|
| 7 |
P. Afolabi, M. Wright, S. A. Wootton, A. A. Jackson. Clinical Utility of 13C-Liver-Function Breath Tests for Assessment of Hepatic Function. Digestive Diseases and Sciences 2013; 58(1): 33 doi: 10.1007/s10620-012-2340-z
|
| 8 |
James D. Perkins. Reversibility of posttransplantation diabetes mellitus following liver transplantation. Liver Transplantation 2009; 15(11): 1631 doi: 10.1002/lt.21901
|
| 9 |
R. Todd Stravitz, Adrian Reuben, Meir Mizrahi, Gadi Lalazar, Kim Brown, Stuart C. Gordon, Yaron Ilan, Arun Sanyal. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation. Journal of Hepatology 2015; 63(6): 1345 doi: 10.1016/j.jhep.2015.07.021
|
| 10 |
Yotam Kolben, Ariel Kenig, Asa Kessler, Yuval Ishay, Sarah Weksler-Zangen, Mualem Eisa, Yaron Ilan. Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial. Transplant International 2023; 36 doi: 10.3389/ti.2023.11176
|
| 11 |
Josef A Vogt, Peter Radermacher, Michael Georgieff. 13CO2 breath tests, a tool to assess intestinal and liver function in the ICU?. Current Opinion in Critical Care 2010; 16(2): 169 doi: 10.1097/MCC.0b013e3283376739
|
| 12 |
R. Todd Stravitz, Yaron Ilan. Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?. Liver International 2017; 37(3): 328 doi: 10.1111/liv.13268
|
| 13 |
JF Lock, P Taheri, S Bauer, HG Holzhütter, M Malinowski, P Neuhaus, M Stockmann. Interpretation of non-invasive breath tests using 13C-labeled substrates - a preliminary report with 13C-methacetin. European Journal of Medical Research 2009; 14(12): 547 doi: 10.1186/2047-783X-14-12-547
|
| 14 |
|
| 15 |
Keyur Patel. Noninvasive tools to assess liver disease. Current Opinion in Gastroenterology 2010; 26(3): 227 doi: 10.1097/MOG.0b013e3283383c68
|
| 16 |
Kevin C. Cossel, Eleanor M. Waxman, Ian A. Finneran, Geoffrey A. Blake, Jun Ye, Nathan R. Newbury. Gas-phase broadband spectroscopy using active sources: progress, status, and applications [Invited]. Journal of the Optical Society of America B 2017; 34(1): 104 doi: 10.1364/JOSAB.34.000104
|
| 17 |
Anton Amann, Wolfram Miekisch, Jochen Schubert, Bogusław Buszewski, Tomasz Ligor, Tadeusz Jezierski, Joachim Pleil, Terence Risby. Analysis of Exhaled Breath for Disease Detection. Annual Review of Analytical Chemistry 2014; 7(1): 455 doi: 10.1146/annurev-anchem-071213-020043
|
| 18 |
Dong Zhu, Hui Zhang, Jing-Yi Mao, Hong-Yan Wang, Xin Li, You-Qing Xu. Role of the <sup>13</sup>C-methacetin breath test in the assessment of acute liver injury in a rat model. World Journal of Gastroenterology 2014; 20(32): 11305-11312 doi: 10.3748/wjg.v20.i32.11305
|
| 19 |
Robert J. Fontana, R. Todd Stravitz, Valerie Durkalski, James Hanje, Bilal Hameed, David Koch, Adrian Reuben, Daniel Ganger, Jody Olson, Iris Liou, Brendan M. McGuire, Kristen Clasen, William M. Lee. Prognostic Value of the 13C‐Methacetin Breath Test in Adults with Acute Liver Failure and Non‐acetaminophen Acute Liver Injury. Hepatology 2021; 74(2): 961 doi: 10.1002/hep.31783
|